Inhibikase Therapeutics, Inc.
NASDAQ:IKTBiotechnology
Healthcare
$1.30 +3.57%
+$0.06 today
- Market cap
- $182.35M
- Beta
- 0.97
- P/E (TTM)
- -3.4
- EPS (TTM)
- -$0.52
52W Low $1.33High $2.26
Volume 0.50M
Average 1.03M
Price history
Inhibikase Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-15.03%
Period high
$2.52
Period low
$1.30
Latest
$1.30
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Oct 21, 2026 | Oct 21, 2026 | |
| 3 | Oct 21, 2026 | Oct 21, 2026 | |
| 8-K | Oct 20, 2026 | Oct 20, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| 8-K | Aug 26, 2026 | Aug 26, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| S-8 | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 4 | Jul 31, 2026 | Jul 31, 2026 | |
| 4 | Jul 31, 2026 | Jul 31, 2026 |
Competitors
Who does Inhibikase Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about IKT's filings, answered from its disclosures.
What is the latest IKT filing?
The latest filing shown is 8-K dated Nov 10, 2026.
How many recent filings does IKT have?
Intrinsic Alpha currently shows 20 recent filings for IKT.
Continue the stock analysis
Jump to another research area for this company.